SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001128732-20-000005
Filing Date
2020-07-15
Accepted
2020-07-15 12:09:52
Documents
1
Period of Report
2019-09-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9213
  Complete submission text file 0001128732-20-000005.txt   10855
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 14464 GOUIN W. #B MONTREAL A8 H9H 1B1
Business Address
Sebaaly Camille (Reporting) CIK: 0001474695 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52898 | Film No.: 201028647